Publication:
In regard to XU et al

dc.contributor.coauthorTopkan E., Somay E.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSelek, Uğur
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:58:53Z
dc.date.issued2024
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.doi10.1016/j.ijrobp.2024.02.044
dc.identifier.issn0360-3016
dc.identifier.issue3
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85195043721
dc.identifier.urihttps://doi.org/10.1016/j.ijrobp.2024.02.044
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27561
dc.identifier.volume119
dc.identifier.wos1252100800001
dc.keywordsAntineoplastic agent
dc.language.isoeng
dc.publisherElsevier Inc.
dc.relation.ispartofInternational Journal of Radiation Oncology Biology Physics
dc.subjectMedicine
dc.titleIn regard to XU et al
dc.typeLetter
dspace.entity.typePublication
local.contributor.kuauthorSelek, Uğur
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files